Para su Difusión
FTC Challenges Grifols/Talecris Merger as Anticompetitive
Fecha
The Federal Trade Commission will require Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma...